Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials.

BMJ · 2015 · PMC4410620 · PMID 25883067

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

of borderline significanceP=0.05actually significant

These analyses showed highly consistent findings with the main results, except for all cause mortality, which became of borderline significance (P=0.05) in the extended versus 12 month regimen comparison.

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.